The Drug Discovery World Podcast

Drug Discovery World (DDW)
undefined
Jul 30, 2026 • 25min

Could protein biologics be a pioneering approach in ophthalmology?

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Reuben Dawkins, CEO of Link Biologics, a company developing protein biologics to treat inflammatory and degenerative conditions. Link is currently developing treatments for Dry Eye Disease and Wet AMD. Bruno chats to Reuben about why Link chose to target Dry Eye Disease with its pioneering approach, how the company saw an opportunity to compete with current treatments for Wet AMD, and whether the science behind Link's protein biologics could be used beyond ophthalmology. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jul 14, 2026 • 15min

DDW Highlights: 14 July 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a nanoparticle vaccine showed potential to protect from a 'tripledemic'. Elsewhere, could 'magic mushrooms' treat anorexia? You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jul 7, 2026 • 17min

DDW Highlights: 7 July 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, experts warned patients were being denied access to personalised cancer care. Cancer research was a theme elsewhere, with findings emerging from studies into a CAR T-cell therapy, lung cancer and breast cancer. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jul 2, 2026 • 18min

How AI has revolutionised clinical development

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical & Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities in the drug development timeline. One of these solutions is AI. Suzanne discusses what it means for a company to be 'AI-native', how the combination of AI and Real World Data is transforming clinical development, and how AI is enabling companies to get treatments to patients faster. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jun 30, 2026 • 17min

DDW Highlights: 30 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers uncovered clues explaining risks of heart disease, lung disease, Covid-19 and cancer. Elsewhere, find out what is included in the latest issue of DDW. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jun 23, 2026 • 12min

DDW Highlights: 23 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, results showed the new Wegovy pill could help patients lose 17% of their body weight. Elsewhere, advances were made in both cancer treatment and cancer research. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jun 18, 2026 • 17min

Could a new weight loss approach have longer term benefits than GLP-1s?

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Vincent Marion, Scientific Founder and President of AdipoPharma. AdipoPharma is a biotech leveraging research on insulin resistance and adipose tissue biology, developing a new treatment for metabolic diseases. Vincent discusses what makes AdipoPharma's lead asset different from GLP-1s, why findings into fat tissue dysfunction have been less explored in drug development, and how AdipoPharma is competing in an industry where GLP-1s are becoming increasingly accessible. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jun 16, 2026 • 15min

DDW Highlights: 16 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research showed anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for early-career researchers. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jun 9, 2026 • 14min

DDW Highlights: 9 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a cancer drug demonstrated it could reduce tumours by as much as 55%. Elsewhere, AI was a recurrent theme in both clinical trials and drug development. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
undefined
Jun 4, 2026 • 21min

Could a new approach determine the future of cancer treatment?

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Terry Connolly and Shinta Cheng from K36 Therapeutics. K36 is a company developing first-in-class cancer therapeutics and their current lead asset is a treatment for multiple myeloma patients. Bruno speaks to Terry and Shinta about how their NSD2 inhibitors can treat cancer, how their approach compares to other biotechs, and why K36's science could be applied to other therapeutic areas. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app